Metraipolis › archive › dc_f503ee5ac37a

SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer — Europe PMC PMID:41303856

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303856
DOI
10.3390/medicina61112020
License (as archived)
solo-consultazione
Archived
2026-11-08T15:29:00.594Z
SHA-256 of the archived text
fa91004d43b4b4a7b973bf952a0cb8e503b08237f0dc86cd51d69ecad4c360f4
Stable URL of this page
https://metraipolis.com/documento/dc_f503ee5ac37a

How to cite

SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer — Europe PMC PMID:41303856 — Europe PMC (en), https://europepmc.org/article/MED/41303856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f503ee5ac37a (Metraipolis archive dc_f503ee5ac37a, sha256 fa91004d43b4b4a7b973bf952a0cb8e503b08237f0dc86cd51d69ecad4c360f4)
BibTeX
@misc{dcf503ee5ac37a,
  title = {SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer — Europe PMC PMID:41303856},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303856},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f503ee5ac37a; sha256 fa91004d43b4b4a7b973bf952a0cb8e503b08237f0dc86cd51d69ecad4c360f4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303856. Agents can read the archived copy with the MCP tool read_document.